{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:56:32Z","timestamp":1786985792036,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,25]],"date-time":"2024-03-25T00:00:00Z","timestamp":1711324800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.cca.2024.117880","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T22:38:48Z","timestamp":1711665528000},"page":"117880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus"],"prefix":"10.1016","volume":"558","author":[{"given":"Li-Hsin","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ting","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Huei","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Chou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0334-790X","authenticated-orcid":false,"given":"Liang-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.cca.2024.117880_b0005","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1016\/j.jfma.2019.07.027","article-title":"Diabetes-related kidney, eye, and foot disease in Taiwan: an analysis of nationwide data from 2005 to 2014","volume":"118","author":"Lin","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.cca.2024.117880_b0010","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, Progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2024.117880_b0015","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.microc.2017.03.001","article-title":"Characterization and validation of candidate reference methods for the determination of calcium and magnesium in biological fluids","volume":"132","author":"Loai","year":"2017","journal-title":"Microchem. J."},{"key":"10.1016\/j.cca.2024.117880_b0020","first-page":"9596202","article-title":"Salivary distinctiveness and modifications in males with diabetes and beh\u00e7et's disease","volume":"2017","author":"Loai","year":"2017","journal-title":"Biochem. Res. Int."},{"key":"10.1016\/j.cca.2024.117880_b0025","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1291\/hypres.31.433","article-title":"Slower decline of glomerular filtration rate in the japanese general population: a longitudinal 10-year follow-up study","volume":"31","author":"Imai","year":"2008","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.cca.2024.117880_b0030","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2215\/CJN.00580111","article-title":"Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death","volume":"6","author":"Berhane","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2024.117880_b0035","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1093\/ndt\/gfq526","article-title":"The use of eGFR and ACR to predict decline in renal function in people with diabetes","volume":"26","author":"Hoefield","year":"2011","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cca.2024.117880_b0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(18)30313-9","article-title":"Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies","volume":"7","author":"Coresh","year":"2019","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.cca.2024.117880_b0045","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. a collaborative meta-analysis of general and high-risk population cohorts","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2024.117880_b0050","unstructured":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work G. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int 2021;100:S1-S276."},{"key":"10.1016\/j.cca.2024.117880_b0055","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1172\/JCI100690","article-title":"The excretion of inulin, xylose and urea by Normal and phlorizinized man","volume":"14","author":"Shannon","year":"1935","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cca.2024.117880_b0060","first-page":"710","article-title":"Glomerular filtration rate measured by iohexol clearance: a comparison of venous samples and capillary blood spots","volume":"75","author":"Salvador","year":"2015","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.cca.2024.117880_b0065","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/ckj\/sfab042","article-title":"Assessment of kidney function: clinical indications for measured GFR","volume":"14","author":"Ebert","year":"2021","journal-title":"Clin. Kidney J."},{"key":"10.1016\/j.cca.2024.117880_b0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2024.117880_b0075","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJMoa2203769","article-title":"Cystatin C-based equation to estimate GFR without the inclusion of race and sex","volume":"388","author":"Pottel","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2024.117880_b0080","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2337\/diab.43.5.649","article-title":"Progressive decline in renal function in diabetic patients with and without albuminuria","volume":"43","author":"Tsalamandris","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2024.117880_b0085","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2337\/diacare.27.1.195","article-title":"Nonalbuminuric renal insufficiency in type 2 diabetes","volume":"27","author":"MacIsaac","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2024.117880_b0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.diabet.2012.04.001","article-title":"The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients","volume":"38","author":"Halimi","year":"2012","journal-title":"Diabetes Metab."},{"key":"10.1016\/j.cca.2024.117880_b0095","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrneph.2013.272","article-title":"The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?","volume":"10","author":"Muskiet","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cca.2024.117880_b0100","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMra2206346","article-title":"Humoral innate immunity and acute-phase proteins","volume":"388","author":"Mantovani","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2024.117880_b0105","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s11892-013-0385-9","article-title":"Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors","volume":"13","author":"Gohda","year":"2013","journal-title":"Curr. Diab. Rep."},{"key":"10.1016\/j.cca.2024.117880_b0110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1681\/ASN.2011060627","article-title":"Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes","volume":"23","author":"Niewczas","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2024.117880_b0115","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4158\/EP-2020-0114","article-title":"Soluble tumor necrosis factor receptor type 1 levels exhibit a stronger association with renal outcomes than traditional risk factors in chinese subjects with type 2 diabetes mellitus","volume":"26","author":"Chang","year":"2020","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.cca.2024.117880_b0120","doi-asserted-by":"crossref","unstructured":"A.E. Nuha, A. Grazia, R.A. Vanita et al. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes 2023 Diabetes Care 2023; 46: S191-S202.","DOI":"10.2337\/dc23-S011"},{"key":"10.1016\/j.cca.2024.117880_b0125","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"Suppl 2","key":"10.1016\/j.cca.2024.117880_b0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1464-5491.2008.02496.x","article-title":"Microvascular disease: what does the UKPDS tell us about diabetic nephropathy?","volume":"25","author":"Bilous","year":"2008","journal-title":"Diabet. Med."},{"key":"10.1016\/j.cca.2024.117880_b0135","first-page":"e3556","article-title":"Review of Potential Biomarkers of Inflammation and Kidney Injury in Diabetic Kidney Disease Diabetes","volume":"38","author":"Khanijou","year":"2022","journal-title":"Metab. Res. Rev."},{"issue":"4","key":"10.1016\/j.cca.2024.117880_b0140","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ki.2014.330","article-title":"Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American indians with type 2 diabetes","volume":"87","author":"Pavkov","year":"2015","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.cca.2024.117880_b0145","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.kint.2017.02.010","article-title":"Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease","volume":"92","author":"Yamanouchi","year":"2017","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2024.117880_b0150","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2337\/dc13-2580","article-title":"Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE cohort","volume":"37","author":"Saulnier","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2024.117880_b0155","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/s00125-018-4741-9","article-title":"Serum kidney injury molecule 1 and beta2-microglobulin perform as well as larger biomarker panels for prediction of rapid decline in renal function in type 2 diabetes","volume":"62","author":"Colombo","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.cca.2024.117880_b0160","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/s41591-019-0415-5","article-title":"A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetes","volume":"25","author":"Niewczas","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2024.117880_b0165","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1007\/s40618-021-01568-7","article-title":"The combination of soluble tumor necrosis factor receptor type 1 and fibroblast growth factor 21 exhibits better prediction of renal outcomes in patients with type 2 diabetes mellitus","volume":"44","author":"Chang","year":"2021","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.cca.2024.117880_b0170","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2337\/dc17-1919","article-title":"High baseline levels of tumor necrosis factor receptor 1 are associated with progression of kidney disease in indigenous australians with diabetes: the eGFR follow-up study","volume":"41","author":"Barr","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2024.117880_b0175","doi-asserted-by":"crossref","first-page":"e1918169","DOI":"10.1001\/jamanetworkopen.2019.18169","article-title":"Clinical Characteristics of and risk factors for chronic kidney disease among adults and children: an analysis of the CURE-CKD registry","volume":"2","author":"Tuttle","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"Suppl 2","key":"10.1016\/j.cca.2024.117880_b0180","doi-asserted-by":"crossref","first-page":"S130","DOI":"10.1016\/j.jfma.2019.06.018","article-title":"2019 diabetes atlas: achievements and challenges in diabetes care in Taiwan","volume":"118","author":"Hsu","year":"2019","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.cca.2024.117880_b0185","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/s13054-019-2684-2","article-title":"Plasma sTNFR1 and IL8 for prognostic enrichment in sepsis trials: a prospective cohort study","volume":"23","author":"Brian","year":"2019","journal-title":"Crit. Care"},{"key":"10.1016\/j.cca.2024.117880_b0190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.18053\/jctres.02.201603.005","article-title":"The role of TNF-\u03b1 in rheumatoid arthritis: a focus on regulatory T cells","volume":"2","author":"Farrugia","year":"2016","journal-title":"J. Clin. Transl. Res."},{"key":"10.1016\/j.cca.2024.117880_b0195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cca.2014.09.001","article-title":"Inflammatory Cytokines as Biomarkers in Heart Failure","volume":"443","author":"Ueland","year":"2015","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.cca.2024.117880_b0200","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.656928","article-title":"Serum soluble tumor necrosis factor receptors 1 and 2 are early prognosis markers after ST-Segment elevation myocardial infarction","volume":"12","author":"Paccalet","year":"2021","journal-title":"Front Pharmacol."},{"key":"10.1016\/j.cca.2024.117880_b0205","first-page":"1867","volume":"65","author":"Schiborn","year":"2022","journal-title":"Precision Prognostics for the Development of Complications in Diabetes Diabetologia."},{"key":"10.1016\/j.cca.2024.117880_b0210","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/jama.2011.451","article-title":"A predictive model for progression of chronic kidney disease to kidney failure","volume":"305","author":"Tangri","year":"2011","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.cca.2024.117880_b0215","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41581-021-00393-8","article-title":"Pathophysiology of diabetic kidney disease: impact of SGLT2 inhibitors","volume":"17","author":"DeFronzo","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cca.2024.117880_b0220","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment","volume":"28","author":"Tonneijck","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2024.117880_b0225","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00592-011-0349-y","article-title":"Structural damage in diabetic nephropathy is associated with TNF-alpha system activity","volume":"49","author":"Fernandez-Real","year":"2012","journal-title":"Acta Diabetol."},{"key":"10.1016\/j.cca.2024.117880_b0230","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ki.2015.278","article-title":"Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes","volume":"89","author":"Pavkov","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2024.117880_b0235","doi-asserted-by":"crossref","first-page":"14852","DOI":"10.1038\/s41598-020-71684-6","article-title":"Parallel assessment of albuminuria and plasma sTNFR1 in people with type 2 diabetes and advanced chronic kidney disease provides accurate prognostication of the risks of renal decline and death","volume":"10","author":"William","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2024.117880_b0240","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2337\/dc16-1571","article-title":"Association of Circulating Biomarkers (adrenomedullin, TNFR1, and NT-proBNP) with renal function decline in patients with type 2 diabetes: a french prospective cohort","volume":"40","author":"Saulnier","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2024.117880_b0245","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(19)31150-X","article-title":"Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cca.2024.117880_b0250","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.semnephrol.2016.05.005","article-title":"The role of acute kidney injury in chronic kidney disease","volume":"36","author":"Hsu","year":"2016","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cca.2024.117880_b0255","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.2215\/CJN.10321014","article-title":"Risk prediction for Early CKD in type 2 diabetes","volume":"10","author":"Dunkler","year":"2015","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2024.117880_b0260","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.2337\/dc13-0190","article-title":"Derivation and validation of a renal risk score for people with type 2 diabetes","volume":"36","author":"Elley","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2024.117880_b0265","doi-asserted-by":"crossref","first-page":"S191","DOI":"10.2337\/dc23-S011","article-title":"11. chronic kidney disease and risk Management: Standards of Care in Diabetes-2023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.cca.2024.117880_b0270","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2024.117880_b0275","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N. Engl. J. Med."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124001219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898124001219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T20:26:36Z","timestamp":1717187196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898124001219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":55,"alternative-id":["S0009898124001219"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2024.117880","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble tumor necrosis factor receptor type 1 is an alternative marker of urinary albumin-creatinine ratio and estimated glomerular filtration rate for predicting the decline of renal function in subjects with type 2 diabetes mellitus","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2024.117880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117880"}}